Ruplizumab
Source: Wikipedia, the free encyclopedia.
Monoclonal antibody
Humanized (from mouse) | |
---|---|
Target | CD154 |
Clinical data | |
Trade names | Antova |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
NY (what is this?) (verify) |
Ruplizumab (trade name Antova) is a
systemic lupus erythematosus and lupus nephritis. A study showed that the drug was associated with life-threatening thromboembolisms,[1] while another study only found thrombocytopenia.[2]
References
Intracellular (initiation) |
| ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Intracellular (reception) |
| ||||||||||||||
Extracellular |
| ||||||||||||||
Unsorted |
|
This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |
drug article is a stub. You can help Wikipedia by expanding it. |